Results 11 to 20 of about 6,582 (154)

Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey

Health Science Reports, Volume 6, Issue 12, December 2023., 2023
Abstract Background and Aims Involving patients in research, not only as trial subjects, is not a newly established practice. Over the last two decades, patient roles have gradually expanded to become active research contributors, creating a more patient‐centered research landscape.
Ivana Nohová, John Andrews, Bénédicte Votan, Austin Miller, Jalid Sehouli, Regina Berger   +5 more
wiley   +1 more source

Causes of pregnancy arrest in the canine species

Reproduction in Domestic Animals, Volume 58, Issue S2, Page 72-83, September 2023., 2023
Abstract In the canine species, early pregnancy arrest before 30–40 days of pregnancy will induce intra‐uterine embryonic or foetal resorption, with very few clinical signs. If no genital examination by ultrasound is performed at that time, it will often remain unnoticed and the bitch will be qualified as infertile. It is only when pregnancy stops at a
Alain Fontbonne
wiley   +1 more source

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

Cancer, Volume 129, Issue 12, Page 1846-1855, 15 June 2023., 2023
Abstract Background The PRIMA/ENGOT‐OV26/GOG‐3012 (NCT02655016) trial was amended to prospectively evaluate the safety and efficacy of an individualized starting dose (ISD) regimen of niraparib for first‐line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
Mansoor R. Mirza, Antonio González‐Martín, Whitney S. Graybill, David M. O’Malley, Lydia Gaba, Oi Wah Stephanie Yap, Eva M. Guerra, Peter G. Rose, Jean‐François Baurain, Sharad A. Ghamande, Hannelore Denys, Emily Prendergast, Carmela Pisano, Philippe Follana, Klaus Baumann, Paula M. Calvert, Jacob Korach, Yong Li, Izabela A. Malinowska, Divya Gupta, Bradley J. Monk   +20 more
wiley   +1 more source

Top advances of the year: Cervical cancer

Cancer, Volume 129, Issue 5, Page 657-663, 1 March 2023., 2023
Abstract Cervical cancer continues to affect women in the United States and throughout the world despite an effective vaccine against human papillomavirus and cancer screening programs. For the women who develop cervical cancer, surgery, radiation, and chemotherapy have been the mainstays of treatment for years.
Sarah E. Podwika, Linda R. Duska
wiley   +1 more source

Sinonasal inverted papilloma – malignant transformation and non‐sinonasal malignancies

The Laryngoscope, Volume 133, Issue 3, Page 506-511, March 2023., 2023
Objectives To assess malignant transformation rate, non‐sinonasal malignancies, and factors contributing to recurrence in patients treated for sinonasal inverted papilloma (SNIP). Study Design Retrospective study. Methods We retrospectively reviewed medical records of all patients treated for SNIP (n = 296) between the years 1984–2014 at Helsinki ...
Sanna Viitasalo, Taru Ilmarinen, Leena‐Maija Aaltonen, Jaana Hagström, Maija Hytönen, Sari Hammarén‐Malmi, Petra Pietarinen, Pia Järvenpää, Teemu Kinnari, Ahmed Geneid, Markus Lilja   +10 more
wiley   +1 more source

Benign descriptors and ADNEX in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort

Ultrasound in Obstetrics &Gynecology, Volume 61, Issue 2, Page 231-242, February 2023., 2023
ABSTRACT Objective Previous work has suggested that the ultrasound‐based benign simple descriptors (BDs) can reliably exclude malignancy in a large proportion of women presenting with an adnexal mass. This study aimed to validate a modified version of the BDs and to validate a two‐step strategy to estimate the risk of malignancy, in which the modified ...
C. Landolfo, T. Bourne, W. Froyman, B. Van Calster, J. Ceusters, A. C. Testa, L. Wynants, P. Sladkevicius, C. Van Holsbeke, E. Domali, R. Fruscio, E. Epstein, D. Franchi, M. J. Kudla, V. Chiappa, J. L. Alcazar, F. P. G. Leone, F. Buonomo, M. E. Coccia, S. Guerriero, N. Deo, L. Jokubkiene, L. Savelli, D. Fischerova, A. Czekierdowski, J. Kaijser, A. Coosemans, G. Scambia, I. Vergote, D. Timmerman, L. Valentin   +30 more
wiley   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial. [PDF]

CA Cancer J Clin
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Wu L, Wang J, Li Q, Wang D, Zhang C, Tang J, Zhang G, Hao M, Yao D, Gao Q, Zhang Y, An R, Yin R, Wang L, Xia B, Zhou Q, Yang H, Zhu J, Jiang K, Chen Z, Wu Q, Duan W, Huang Y, Zhang H, Wei S, Li G, Meng Y, Wang K, Yang X, Huang X, Pan L, Yu J, Lou G, Zhang Y, Zhou H, Guo X, Yang H, Cheng X, Li X, Wang W, Zhao H, Li Y, Yang Y, Lin A, Cheng W, Chen L, Xie X, Di W, Hu Y, Chen M, Wen H, Cai L, Wu X, Lin Z, Wang Q, Yang X, Li N.   +56 more
europepmc   +2 more sources

Síndrome do ovário policístico em adolescente: revisão integrativa [PDF]

, 2023
OBJETIVO: Esclarecer as estratégias diagnósticas e condutas terapêuticas em adolescentes por meio de uma revisão integrativa. FONTE DE DADOS: Trata-se de uma revisão integrativa da literatura que utilizará como fonte de dados o PubMed, Scielo e Bancos de
Baltazar, Beatriz Torres, Silva, Marcelane de Lira, Procópio, José Valdilânio Virgulino, Seabra, Cicera Amanda Mota, Gabriel, Igor de Sousa   +4 more
core   +1 more source

Radioimunoterapia: uma abordagem terapêutica promissora no tratamento do carcinoma do ovário [PDF]

, 2022
O cancro do ovário é a neoplasia ginecológica com maior índice de mortalidade entre a população do sexo feminino apesar dos consideráveis progressos verificados no seu tratamento.
Maria Cristina Oliveira, Oliveira, Maria Cristina, Rodrigues, Carolina, Carolina Rodrigues   +3 more
core   +1 more source

ADENOCARCINOMA DE OVÁRIO E SUA RELAÇÃO COM A ENDOMETRIOSE

, 2023
O câncer de ovário é uma das neoplasias mais letais devido ao diagnóstico tardio. Por não haver sintomatologia nas fases iniciais da doença o diagnóstico torna-se difícil, acarretando uma alta mortalidade e fazendo-se necessária a busca por meios de ...
Chaves, Nayra Teresa de Castro Pereira, Melo, Mayara Magna de Lima   +1 more
core   +1 more source